Trabectedin in ovarian cancer: Could we expect more?

C. Sessa; M. D'Incalci

doi:10.1093/annonc/mdq641

Trabectedin in ovarian cancer: Could we expect more?

C. Sessa, M. D'Incalci

Istituto di Ricerche Farmacologiche "Mario Negri"

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	7-8
Number of pages	2
Journal	Annals of Oncology
Volume	22
Issue number	1
DOIs	https://doi.org/10.1093/annonc/mdq641
Publication status	Published - 2011

ASJC Scopus subject areas

Oncology
Hematology

Access to Document

10.1093/annonc/mdq641

Cite this

@article{81eac47845b345e48c0bbb382520cc8c,

title = "Trabectedin in ovarian cancer: Could we expect more?",

author = "C. Sessa and M. D'Incalci",

year = "2011",

doi = "10.1093/annonc/mdq641",

language = "English",

volume = "22",

pages = "7--8",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "1",

}

TY - JOUR

T1 - Trabectedin in ovarian cancer

T2 - Could we expect more?

AU - Sessa, C.

AU - D'Incalci, M.

PY - 2011

Y1 - 2011

UR - http://www.scopus.com/inward/record.url?scp=78650385830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650385830&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdq641

DO - 10.1093/annonc/mdq641

M3 - Article

C2 - 21059638

AN - SCOPUS:78650385830

VL - 22

SP - 7

EP - 8

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 1

ER -

Trabectedin in ovarian cancer: Could we expect more?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this